Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell Therapy

Conditions:   Recurrent Aggressive Non-Hodgkin Lymphoma;   Recurrent Diffuse Large B-Cell Lymphoma;   Recurrent High Grade B-Cell Lymphoma;   Recurrent Malignant Neoplasm;   Recurrent Plasma Cell Myeloma;   Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma;   Refractory  Aggressive Non-Hodgkin Lymphoma;   Refractory Diffuse Large B-Cell Lymphoma;   Refractory High Grade B-Cell Lymphoma;   Refractory Malignant Neoplasm;   Refractory Plasma Cell Myeloma;   Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Interventions:   Radiation: Fluorine F 18-fluoroazomycin Arabinoside;   Procedure: Positron Emission Tomography Sponsor:   University of California, San Francisco Suspended
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials